AwesomeCapital
Search This Blog
Wednesday, November 27, 2024
FDA investigating safety risks of bluebird's Skysona
The FDA said it is evaluating the need for additional regulatory action regarding the safety of bluebird bio's (BLUE) gene therapy
https://seekingalpha.com/news/4341034-fda-investigating-safety-risks-of-bluebirds-skysona
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.